7Baggers

Deere & Quarterly Cash Flow Statements Chart

Quarterly
 | 
Annual
 
 Operating Cash Flow  
 Investing Cash Flow  
 Financing Cash Flow  
 Free Cash Flow  
 Capital Expenditure  
20201101 20210131 20210502 20210801 20211031 20220130 20220501 20220731 20221030 20230129 20230430 20230730 20231029 20240128 20240428 20240728 20241027 20250126 20250427 20250727 -4.14-3.09-2.04-10.051.12.153.19Billion

Deere & Quarterly Cash Flow Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-07-27 2025-04-27 2025-01-26 2024-10-27 2024-07-28 2024-04-28 2024-01-28 2023-10-29 2023-07-30 2023-04-30 2023-01-29 2022-10-30 2022-07-31 2022-05-01 2022-01-30 2021-10-31 2021-08-01 2021-05-02 2021-01-31 2020-11-01 2020-08-02 2020-05-03 2020-02-02 2019-04-28 2019-01-27 2018-07-29 2018-04-29 2018-01-28 2017-07-30 2017-04-30 2017-01-29 2016-04-30 2016-01-31 
                                   
  cash flows from operating activities                                 
  net income1,271,000,000 1,800,000,000 867,000,000  1,730,000,000 2,368,000,000 1,748,000,000  2,972,000,000 2,858,000,000 1,957,000,000  1,885,000,000 2,097,000,000 904,000,000 402,000,000 1,668,000,000 1,790,000,000 1,224,000,000 192,000,000 811,000,000 666,000,000 518,000,000 1,136,300,000 499,600,000 911,300,000 1,209,600,000 -534,700,000 653,100,000 802,200,000 193,200,000 494,700,000 253,800,000 
  adjustments to reconcile net income to net cash from operating activities:                                 
  benefit from credit losses84,000,000 105,000,000 69,000,000                     34,100,000 2,500,000 39,300,000 24,300,000 2,500,000 44,200,000 26,100,000 6,500,000 25,700,000 9,400,000 
  benefit from depreciation and amortization564,000,000 555,000,000 549,000,000  553,000,000 525,000,000 520,000,000  532,000,000 501,000,000 494,000,000             513,200,000 503,300,000 494,000,000 487,600,000 463,200,000 435,900,000 427,400,000 415,700,000 387,600,000 374,200,000 
  impairments and other adjustments61,000,000 -32,000,000                              
  share-based compensation expense50,000,000 26,000,000 28,000,000  55,000,000 58,000,000 46,000,000  58,000,000 31,000,000 23,000,000             24,100,000 20,300,000 23,000,000 23,100,000 16,700,000 18,400,000 14,100,000 18,200,000 14,500,000 17,500,000 
  credit for deferred income taxes    -5,000,000                             
  changes in assets and liabilities:                                 
  receivables related to sales575,000,000 -2,132,000,000 1,063,000,000  23,000,000 -2,192,000,000 -277,000,000  -652,000,000                         
  inventories246,000,000 23,000,000 -795,000,000  643,000,000 314,000,000 -723,000,000  319,000,000 297,000,000 -1,279,000,000             1,600,000 -1,395,900,000 258,000,000 -558,000,000 -1,238,800,000 -257,600,000 -347,300,000 -743,100,000 159,500,000 -565,300,000 
  accounts payable and accrued expenses181,000,000 947,000,000 -1,845,000,000  285,000,000 1,027,000,000 -2,327,000,000  360,000,000 1,264,000,000 -1,577,000,000             631,100,000 -697,500,000 -93,900,000 1,222,000,000 -915,100,000 212,600,000 821,300,000 -717,700,000 501,700,000 -869,500,000 
  accrued income taxes payable/receivable393,000,000 -540,000,000  60,000,000 -212,000,000 183,000,000  -499,000,000 -295,000,000 199,000,000             59,100,000 97,900,000 22,700,000 -272,100,000 425,100,000 -27,300,000 179,600,000 15,500,000 253,500,000 -241,500,000 
  retirement benefits-19,000,000 -106,000,000 -688,000,000  -38,000,000 -79,000,000 -129,000,000  -48,000,000 -20,000,000 -48,000,000             24,600,000 -4,300,000 -882,300,000 2,000,000 65,600,000 57,500,000 69,100,000 46,500,000 68,300,000 22,800,000 
  other-4,000,000 286,000,000 -16,000,000  -255,000,000 90,000,000 -7,000,000  28,000,000 -38,000,000 186,000,000             183,600,000 -106,300,000 26,500,000 -117,700,000 -19,500,000 -53,900,000 16,200,000 -44,100,000 20,200,000 -76,300,000 
  net cash from operating activities2,896,000,000 1,700,000,000 -1,132,000,000 -4,138,990,769 3,195,000,000 1,852,000,000 -908,000,000 -2,895,991,411 3,043,000,000 1,099,000,000 -1,246,000,000 -417,995,301            155,900,000 -1,650,700,000 547,000,000 75,100,000 -1,296,800,000 904,300,000 567,400,000 -742,400,000 465,200,000 -777,600,000 
  capex-297,000,000 -203,000,000 -352,000,000 -324,000,000 -357,000,000 -362,000,000 -303,000,000 -269,000,000 -315,000,000            -193,500,000 -297,400,000 -218,400,000 -175,900,000 -176,300,000 -120,700,000 -97,800,000 -155,200,000 -92,600,000 -140,000,000 
  free cash flows2,599,000,000 1,497,000,000 -1,484,000,000 -4,138,990,769 2,871,000,000 1,495,000,000 -1,270,000,000 -2,895,991,411 2,740,000,000 830,000,000 -1,561,000,000 -417,995,301            -37,600,000 -1,948,100,000 328,600,000 -100,800,000 -1,473,100,000 783,600,000 469,600,000 -897,600,000 372,600,000 -917,600,000 
  ​                                 
  cash flows from investing activities                                 
  collections of receivables5,364,000,000 6,211,000,000 8,137,000,000  5,440,000,000 5,951,000,000 7,752,000,000  4,999,000,000 5,395,000,000 7,198,000,000             3,678,900,000 5,496,400,000 3,381,000,000 3,554,800,000 5,226,100,000 3,106,400,000 3,413,200,000 4,814,800,000 3,487,200,000 4,633,400,000 
  proceeds from maturities and sales of marketable securities114,000,000 184,000,000 61,000,000  133,000,000                   22,400,000 7,900,000 32,000,000 10,700,000 13,100,000 347,500,000 17,600,000 23,700,000 52,700,000 18,700,000 
  proceeds from sales of equipment on operating leases407,000,000 568,000,000 433,000,000  440,000,000 505,000,000 506,000,000  452,000,000 496,000,000 497,000,000             452,600,000 370,800,000 367,000,000 409,000,000 339,600,000 300,200,000 418,200,000 368,200,000 339,300,000 290,800,000 
  cost of receivables acquired-6,218,000,000 -6,699,000,000 -6,045,000,000  -7,022,000,000 -7,644,000,000 -6,447,000,000  -7,263,000,000 -7,129,000,000 -6,322,000,000             -4,673,900,000 -4,212,800,000 -4,404,400,000 -4,174,600,000 -4,006,600,000 -3,697,000,000 -3,984,000,000 -3,644,600,000 -3,556,300,000 -3,316,600,000 
  acquisitions of businesses, net of cash acquired        -41,000,000                 200,000 -41,400,000 -5,129,700,000      
  purchases of marketable securities-251,000,000 -206,000,000 -141,000,000  -140,000,000                   -28,100,000 -31,500,000 -38,600,000 -38,500,000 -24,300,000 -33,300,000 -22,000,000 -21,700,000 -40,500,000 -71,700,000 
  purchases of property and equipment-297,000,000 -203,000,000 -352,000,000  -324,000,000 -357,000,000 -362,000,000  -303,000,000 -269,000,000 -315,000,000             -193,500,000 -297,400,000 -218,400,000 -175,900,000 -176,300,000 -120,700,000 -97,800,000 -155,200,000 -92,600,000 -140,000,000 
  cost of equipment on operating leases acquired-755,000,000 -815,000,000 -439,000,000  -796,000,000 -915,000,000 -454,000,000  -739,000,000 -732,000,000 -497,000,000             -562,700,000 -361,400,000 -501,200,000 -560,800,000 -365,700,000 -470,200,000 -542,500,000 -382,600,000 -633,700,000 -570,400,000 
  collections of receivables from unconsolidated affiliates100,000,000                                 
  collateral on derivatives – net100,000,000 218,000,000 -191,000,000  294,000,000 -214,000,000 310,000,000                           
  net cash from investing activities-1,580,000,000 -637,000,000 1,416,000,000 3,670,993,536 -2,001,000,000 -2,887,000,000 1,217,000,000 4,562,991,251 -3,069,000,000 -2,254,000,000 760,000,000 4,429,991,515            -1,340,800,000 968,600,000 -1,312,000,000 -1,062,700,000 -4,090,300,000 -601,700,000 -803,900,000 1,104,400,000 -641,600,000 851,600,000 
  cash flows from financing activities                                 
  net payments in short-term borrowings  -1,484,000,000                               
  proceeds from borrowings issued5,551,000,000 1,988,000,000 3,168,000,000  5,323,000,000 4,902,000,000 5,287,000,000                           
  payments of borrowings-2,906,000,000 -3,084,000,000 -1,753,000,000  -2,653,000,000 -4,902,000,000 -3,237,000,000                           
  repurchases of common stock-298,000,000 -397,000,000 -441,000,000  -805,000,000 -1,094,000,000 -1,328,000,000  -2,117,000,000 -1,289,000,000 -1,257,000,000             -336,500,000 -143,900,000 -393,400,000 -50,900,000 -9,700,000 -6,200,000 -97,600,000 -107,800,000 
  dividends paid-439,000,000 -440,000,000 -403,000,000  -406,000,000 -410,000,000 -386,000,000  -368,000,000 -356,000,000 -341,000,000             -242,000,000 -220,300,000 -195,700,000 -193,900,000 -193,000,000 -191,800,000 -190,600,000 -188,900,000 -190,100,000 -193,100,000 
  net cash from financing activities-736,000,000 102,000,000 -923,000,000 788,997,283 373,000,000 1,483,000,000 -2,645,000,000 -3,378,997,192 1,362,000,000 2,356,000,000 -339,000,000 -514,999,174            1,069,400,000 402,800,000 560,700,000 1,326,300,000 -231,000,000 1,584,000,000 840,500,000 -768,500,000 763,800,000 -742,900,000 
  effect of exchange rate changes on cash, cash equivalents, and restricted cash88,000,000 107,000,000 -87,000,000 5,999,963 -1,000,000 -21,000,000 16,000,000 -124,999,969 55,000,000 8,000,000 62,000,000 142,999,776            -21,900,000 -12,900,000         
  net increase in cash, cash equivalents, and restricted cash668,000,000   327,000,013 1,566,000,000   -1,836,997,321 1,391,000,000   3,639,996,816                      
  cash, cash equivalents, and restricted cash at beginning of period7,633,000,000  7,620,000,000  4,941,000,000             4,015,300,000         
  cash, cash equivalents, and restricted cash at end of period668,000,000 1,272,000,000 6,907,000,000  1,566,000,000 427,000,000 5,300,000,000  1,391,000,000 1,209,000,000 4,178,000,000  506,000,000 -590,000,000 4,569,000,000  358,000,000 217,000,000 7,064,000,000  -703,000,000 5,293,000,000 3,710,000,000 -137,400,000 3,723,100,000         
  components of cash, cash equivalents, and restricted cash                                 
  cash and cash equivalents589,000,000 1,390,000,000 6,601,000,000  1,451,000,000 416,000,000 5,137,000,000  1,309,000,000 1,291,000,000 3,976,000,000  481,000,000                     
  cash, cash equivalents, and restricted cash  116,000,000                               
  restricted cash79,000,000 -2,000,000 190,000,000  7,000,000 11,000,000 163,000,000  82,000,000 -82,000,000 202,000,000                       
  total cash, cash equivalents, and restricted cash668,000,000 1,272,000,000 6,907,000,000  1,566,000,000 427,000,000 5,300,000,000  1,391,000,000 1,209,000,000 4,178,000,000  506,000,000                     
  provision (credit) for deferred income taxes      27,000,000   -321,000,000 -56,000,000             -226,500,000 -55,700,000 36,500,000   22,900,000     
  net proceeds in short-term borrowings                                 
  benefit from deferred income taxes  208,000,000                         479,700,000   6,000,000 -147,100,000 240,400,000 
  net decrease in cash, cash equivalents, and restricted cash  -726,000,000    -2,320,000,000    -763,000,000             -137,400,000 -292,200,000         
  provision (credit) for credit losses    91,000,000 100,000,000 31,000,000  25,000,000 41,000,000 -130,000,000                       
  net proceeds      -2,951,000,000                           
  other non-cash adjustments                                 
  gain on remeasurement of previously held equity investment                                 
  collateral on derivatives - net        -127,000,000 22,000,000 345,000,000                       
  increase in total short-term borrowings        1,048,000,000 3,295,000,000 697,000,000             1,094,100,000 476,300,000 984,300,000   1,465,800,000   1,113,200,000 -1,074,900,000 
  proceeds from long-term borrowings        5,104,000,000 2,363,000,000 2,505,000,000             2,021,100,000 2,211,100,000 1,661,400,000 1,815,600,000 2,262,100,000 1,702,900,000 1,365,800,000 1,295,800,000 1,444,600,000 1,832,000,000 
  payments of long-term borrowings        -2,295,000,000 -1,642,000,000 -1,925,000,000             -1,485,500,000 -1,941,300,000 -1,483,100,000 -1,017,500,000 -1,871,200,000 -1,463,400,000 -1,693,300,000 -1,048,900,000 -1,505,300,000 -1,181,300,000 
  proceeds from sales of businesses and unconsolidated affiliates, net of cash sold                         78,000,000 5,300,000 49,700,000 113,900,000   
  proceeds from issuance of common stock         9,000,000 21,000,000             43,600,000 51,100,000 10,100,000 55,600,000 143,000,000 105,000,000 120,300,000 263,300,000 8,400,000 2,700,000 
  trade, notes, and financing receivables related to sales          -1,015,000,000             -2,224,000,000 -507,300,000         
  impairment charges                               37,100,000 12,600,000 
  undistributed earnings of unconsolidated affiliates                       -1,300,000 -7,300,000 -5,300,000 2,100,000 -6,600,000 -6,200,000 -2,100,000 -1,000,000 5,900,000 -600,000 
  decrease in total short-term borrowings                           -535,500,000   -1,064,900,000   
  loss on sale of businesses and unconsolidated affiliates                                 
  decrease (increase) in trade and wholesale receivables                                 
  change in intercompany receivables/payables                                 
  cash, cash equivalents, and restricted cash at beginning of year                                 
  cash, cash equivalents, and restricted cash at end of year                                 
  (gain) loss on sale of businesses and unconsolidated affiliates                                 
  increase in investment in financial services                                 
  capital investment from equipment operations                                 
  (gain) loss on sales of businesses and unconsolidated affiliates                                 
  gain on sales of businesses                                 
  proceeds from sales of businesses, net of cash sold                                 
  gain on sale of affiliates and investments                         -11,900,000        
  trade, notes and financing receivables related to sales                         -270,900,000 -2,059,200,000 -34,900,000 -101,600,000 -1,051,400,000 61,900,000 -1,356,400,000 44,900,000 
  effect of exchange rate changes on cash and cash equivalents                         -73,800,000 -52,400,000 198,300,000 125,000,000 31,800,000 -39,300,000 85,900,000 -33,400,000 
  net increase in cash and cash equivalents                         -278,100,000   2,011,600,000   673,300,000 -702,300,000 
  cash and cash equivalents at beginning of period                         9,334,900,000 4,335,800,000 4,162,200,000 
  cash and cash equivalents at end of period                         -278,100,000 286,300,000 3,915,100,000 2,011,600,000 635,800,000 3,890,000,000 673,300,000 3,459,900,000 
  net decrease in cash and cash equivalents                           -5,419,800,000   -445,800,000   
  gain on sale of unconsolidated affiliates and investments                            -93,700,000     
  excess tax benefits from share-based compensation                             5,600,000 5,700,000 1,700,000 1,000,000 
  insurance receivables                                 
  proceeds from sale of business, net of cash sold                                 
  cash and cash equivalents at beginning of year                                 
  cash and cash equivalents at end of year                                 
  credit for credit losses                                 
  benefit from doubtful receivables                                 
  provision (credit) for doubtful receivables                                 
  government grants related to property and equipment                                 
  cost of receivables                                 
  increase in short-term borrowings                                 
  proceeds from sales of financing receivables                                 
  goodwill impairment charge                                 
  cost of financing receivables acquired                                 
  gain on the sale of a business                                 
  retirement benefit accruals/prepaid pension costs                                 
  collections of financing receivables                                 
  trade, notes and financing receivables related to sales of equipment                                 
  see notes to interim financial statements.                                 
  undistributed earnings of unconsolidated subsidiaries and affiliates                                 
  receivables                                 
  cost of operating leases acquired                                 
  principal payments on long-term borrowings                                 
  effect of exchange rate changes on cash                                 
  proceeds from sales of businesses                                 
  increase in receivables from unconsolidated affiliates                                 
  increase in receivables with unconsolidated affiliates                                 
  other*                                 
  decrease (increase) in receivables from unconsolidated affiliates                                 
  benefit from doubtful receivable                                 
  proceeds from sale of a business                                 
  purchases of properly and equipment                                 

We provide you with 20 years of cash flow statements for Deere & stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Deere & stock. Explore the full financial landscape of Deere & stock with our expertly curated income statements.

The information provided in this report about Deere & stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.